(Q39828211)

15 September 2017

title

Statin use is associated with improved prostate cancer survival: is it time for a clinical trial? (English)

1 reference

15 September 2017

Teemu J. Murtola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20942627

1 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20942627

1 August 2024

publication date

1 October 2010

1 reference

full work available at URL

15 September 2017

http://www.future-drugs.com/doi/abs/10.1586/era.10.137

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20942627

http://www.tandfonline.com/doi/pdf/10.1586/era.10.137

1 August 2024

1 reference

Expert Review of Anticancer Therapy

1 August 2024

published in

1 reference

15 September 2017

volume

10

1 reference

15 September 2017

issue

10

1 reference

15 September 2017

page(s)

1563-1567

1 reference

Trends in serum lipids and lipoproteins of adults, 1960-2002.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Statin drugs and risk of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Statin use and risk of prostate cancer in the California Men's Health Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Statins and prostate cancer prevention: where we are now, and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

The association between statin use and the diagnosis of prostate cancer in a population based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

The influence of statin medications on prostate-specific antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Statin use and risk of prostate cancer recurrence in men treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Hypercholesterolemia and prostate cancer: a hospital-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Biomarkers for prostate cancer detection and progression: Beyond prostate-specific antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.137

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort

21 January 2018

7

1 reference

Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect

1 August 2024

12

1 reference

Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model

1 August 2024

30

1 reference

Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer

1 August 2024

31

1 reference

1 August 2024

Identifiers

DOI

10.1586/ERA.10.137

1 reference

15 September 2017

1 reference